Product image of Voncento (Human Coagulation Factor Viii, Human Von Willebrand Factor) supplied by GNH India

Voncento

Active Ingredient:
Human Coagulation Factor Viii, Human Von Willebrand Factor
Origin:
EU

Voncento (Human Coagulation Factor Viii, Human Von Willebrand Factor)

Voncento combines Human Coagulation Factor VIII and Human Von Willebrand Factor for hemophilia A management. This intravenous therapy supports blood clotting in patients with von Willebrand disease or factor VIII deficiency. Suitable for prophylactic and on-demand use in bleeding disorders. Reliable EU-sourced option for factor replacement therapy.

Manufacturer / TM Owner

Csl Behring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Voncento is used to treat and prevent bleeding episodes in patients with hemophilia A or von Willebrand disease. It replaces missing or defective clotting factors to support normal blood coagulation. Healthcare providers may recommend it for routine prophylaxis or as needed during procedures or injuries. This therapy helps maintain adequate factor levels for hemostasis.

Side Effects

  • After administration, Voncento works quickly to restore clotting factor activity in the bloodstream. Patients may experience improved bleeding control and reduced frequency of spontaneous bleeds with regular use. The duration of effect varies by individual and dosing regimen. Most users notice symptom improvement within hours of infusion.

Precautions & Warnings

  • Store Voncento refrigerated and protect from light until use. Do not freeze or shake the product. Use only as directed by a healthcare professional. Keep the product in its original packaging until ready to administer. Dispose of any unused medication and supplies properly after preparation.

Avoid Interactions

  • Voncento has no known direct drug interactions, but concurrent use with other clotting therapies should be monitored. Patients using anticoagulants or platelet inhibitors may require adjusted dosing schedules. Always inform healthcare providers about all medications before starting Voncento therapy. No specific food or alcohol restrictions are associated with this product.

Frequently Asked Questions

Voncento is used to treat and prevent bleeding in people with hemophilia A or von Willebrand disease by replacing missing clotting factors.

Voncento is given as an intravenous infusion by a healthcare professional, typically in a clinic or hospital setting.

Yes, Voncento is approved for use in pediatric patients under medical supervision for bleeding disorder management.

Contact your healthcare provider immediately if a dose is missed to determine the appropriate next steps for your treatment plan.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii, Human Von Willebrand Factor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT